Shire Limited, the global specialty biopharmaceutical company announces that on August 5, 2008 it was notified by Mr Matthew Emmens, Chairman of the Company, of the exercise, on the same day, of the following options over ordinary shares of 5 pence each in the Company (the Shares)...
